Related Experiment Video
Updated: May 18, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Prognostic factors for melanoma progression and metastasis: from Hematoxylin-Eosin to genetics
1Department of Pathology, Hospital El Bierzo, Ponferrada, Spain. gpyauflowerlion@terra.es
Abstract:
Researchers have searched for factors that predict the metastatic potential of melanomas for decades. In recent years, the study of their metastatic potential has progressed from routine histological analysis of Hematoxylin-Eosin stained slides to proteomic, genetic, and molecular pathological analyses. As a result, knowledge about the metastatic potential of melanomas has progressed. Hundreds of prognostic factors have been described in literature and it is not possible to mention all of them in a report. Therefore, in the current report, we summarize some of them.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...